Latest News

Prof Karina Butler, Chair of National Immunisation Advisory Committee (NIAC), to speak at Joint Committee on Health

Published 20 April 2021

Prof Karina Butler, Chair of National Immunisation Advisory Committee (NIAC), will explain NIAC's work in providing evidence-based advice to the Chief Medical Officer on immunisation at the Joint Committee on Health which meets at 3:30pm today, 20 April 2021.
Read more

National Immunisation Advisory Committee (NIAC) issues revised advice on the use of the AstraZeneca COVID-19 vaccine

Published 12 April 2021

The National Immunisation Advisory Committee (NIAC) has issued revised advice to the Department of Health on the use of the AstraZeneca COVID-19 vaccine in light of the outcome of the recent investigation by the European Medicines Agency. The EMA has added unusual clotting events with low platelet counts as very rare side effects to the vaccine product information. These rare events are estimated to occur between 4 and 10 in every 1 million people, one of whom may die.
Read more

Statement from the National Immunisation Advisory Committee (NIAC) on the AstraZeneca vaccine

Published 7 April 2021

The National Immunisation Advisory Committee (NIAC) notes the finding from the European Medicines Agency regarding the AstraZeneca vaccine and statements from the UK. The EMA has advised of finding a possible link between the AstraZeneca Covid-19 vaccine and rare blood clotting issues in adults who had received the vaccine. The regulatory agency concluded that the overall benefits of this highly effective vaccine in protecting recipients from severe COVID-19 disease, hospitalisation and death outweigh the risks of this very rare event. NIAC’s current advice regarding the AstraZeneca vaccine still applies.
Read more

National Immunisation Advisory Committee (NIAC) issues updated recommendations on prioritisation groups for COVID-19 vaccination

Published 31 March 2021

The National Immunisation Advisory Committee (NIAC) has issued updated evidence-based recommendations to the Department of Health on prioritisation groups for COVID-19 vaccination.
Read more

The National Immunisation Advisory Committee (NIAC) is recommending resumption of the COVID-19 vaccine AstraZeneca

Published 19 March 2021

The National Immunisation Advisory Committee (NIAC) is recommending resumption of the COVID-19 vaccine AstraZeneca. NIAC strongly encourages everyone to take up COVID-19 vaccination when offered.
Read more

National Immunisation Advisory Committee (NIAC) recommends temporary deferral of the administration of the COVID-19 Vaccine AstraZeneca®

Published 14 March 2021

The National Immunisation Advisory Committee (NIAC) has today (Sunday, 14 March 2021) recommended the temporary deferral of the administration of the COVID-19 Vaccine AstraZeneca®.
Read more

National Immunisation Advisory Committee (NIAC) issues new guidance on prioritisation groups for COVID-19 vaccination

Published 24 February 2021

National Immunisation Advisory Committee (NIAC) issues new guidance on prioritisation groups for COVID-19 vaccination for those aged 65 and older and those aged 16 to 64 with medical conditions that put them at high risk of severe disease.
Read more

Statement from the National Immunisation Advisory Committee regarding its recommendations on the use of the COVID-19 Vaccine AstraZeneca® in older adults

Published 3 February 2021

The National Immunisation Advisory Committee (NIAC) has issued recommendations on the use of the COVID-19 Vaccine AstraZeneca® in older adults.
Read more

Prof Karina Butler, Chair of National Immunisation Advisory Committee, discusses rollout of the COVID-19 vaccine at Joint Oireachtas Committee on Health

Published 17 December 2020

Professor Karina Butler, Chair of the National Immunisation Advisory Committee, was invited to contribute to the discussions on the rollout of the COVID-19 vaccine at the Joint Oireachtas Committee on Health.
Read more